Rockland Technimed Limited

Oxyfusion™ is a stable Nano-emulsion of the FDA approved PFD, that can efficiently deliver ultra pure Oxygen-17 to target tissue at cellular level.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Mahwah, NJ, US
  • Currency USD
  • Founded April 1999
  • Employees 7
  • Incorporation Type C-corp
  • Website oxy-17.com

Company Summary

Rockland Technimed, Ltd. is a Theranostics company, committed to the early diagnosis and treatment of hypoxic injury. Rockland's disruptive Nano-technology OxyFusion™ MRI medium enriched with its patented Oxy-17® process may set the new Gold standard of metabolic imaging.
Oxyfusion™ is a stable Nano-emulsion of the FDA approved PFD, that can efficiently deliver ultra pure Oxygen-17 to target tissue at cellular level.

Team

Advisors

  • Dr William G Bradley MD PhD;FACR
    Unconfirmed
    John Pile-Spellman, MD; FACC; FAHA
    Unconfirmed
    nataniel Reicjek, MD; FACC, FAHA
    Unconfirmed
  • Michael Moseley, PhD. Professor of Radiology Stanford University
    Unconfirmed
    Ravinder Reddy, PhD. Director MMRRCC, Univ of PENN
    Unconfirmed

Previous Investors

  • George E Heinze
    Unconfirmed
    Dr Suhas Pradhan, FACS
    Unconfirmed
    Lawrance Epstein, MD
    Unconfirmed
  • Tilo Glaeser
    Unconfirmed
    Michael kievel
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free